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Abstract
Background: We presented the photoacoustic imaging (PAI) tool and to evaluate whether microcalcifications in breast
tissue can be detected on photoacoustic (PA) images.
Methods: We collected 21 cores containing microcalcifications (n = 11, microcalcification group) and none (n = 10, control
group) in stereotactic or ultrasound (US) guided 8-gauge vacuum-assisted biopsies. Photoacoustic (PA) images were
acquired through ex vivo experiments by transmitting laser pulses with two different wavelengths (700 nm and 800 nm).
The presence of microcalcifications in PA images were blindly assessed by two radiologists and compared with specimen
mammography. A ratio of the signal amplitude occurring at 700 nm to that occurring at 800 nm was calculated for each PA
focus and was called the PAI ratio.
Results: Based on the change of PA signal amplitude between 700 nm and 800 nm, 10 out of 11 specimens containing
microcalcifications and 8 out of 10 specimens without calcifications were correctly identified on blind review; the sensitivity,
specificity, accuracy, positive predictive and negative predictive values of our blind review were 90.91%, 80.0%, 85.71%,
83.33% and 88.89%. The PAI ratio in the microcalcification group was significantly higher than that in the control group (the
median PAI ratio, 2.46 versus 1.11, respectively, P = .001). On subgroup analysis in the microcalcification group, neither
malignant diagnosis nor the number or size of calcification-foci was proven to contribute to PAI ratios.
Conclusion: Breast microcalcifications generated distinguishable PA signals unlike breast tissue without calcifications. So,
PAI, a non-ionizing and non-invasive hybrid imaging technique, can be an alternative in overcoming the limitations of
conventional US imaging.
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Introduction
Mammographic lesions manifested by microcalcifications con-
stitute approximately half of clinically occult breast cancers and
are frequently employed as an indicator of early breast cancer [1–
3]. If microcalcifications detected on mammography are deemed
suspicious for malignancy, a biopsy is required and recently,
among a variety of biopsy approaches, vacuum-assisted biopsy
with stereotactic guidance is mainly chosen. Even though this
method is successful in aiding the diagnosis of breast microcalci-
fications, stereotactic guidance requires mammographic compres-
sion and radiation exposure of the breast [4,5]. In general,
ultrasound (US)-guided vacuum-assisted biopsy is preferred over
mammographic guidance because US guidance offers a number of
advantages over stereotactic guidance: patients can be in a supine
position without compression of the breast and radiation hazards;
images of the procedures can be acquired in real time [4–7].
Although the low visibility of microcalcifications can be one of the
biggest drawbacks of US imaging due to its relative low contrast
resolution, US-guided vacuum-assisted biopsy can be an effective
alternative to stereotactic-guided vacuum-assisted biopsy in the
cases where microcalcifications are visible on US [6,8–10].
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Since photoacoustic imaging (PAI) is a real-time molecular
imaging modality with high spatial and contrast resolutions, it may
be an alternative for the imaging of breast microcalcifications in
real time [11–13]. The PAI technology has been applied to various
areas, such as tumor angiogenesis studies, functional brain studies,
and deep internal organ imaging in animals [13–17]. Previous
reports about PAI for real-time detection of breast microcalcifi-
cations were performed in order to determine optimal laser
wavelength that was found to be 700 nm. In fact, the laser energy
absorbance consistently decreases from 700 nm to the near-
infrared spectrum range. By using the unique absorbance
spectrum, 3-dimensional spectroscopic photoacoustic (PA) images
of breast specimens were proposed [18,19].
In this paper, we present the PAI tool and evaluate whether
microcalcifications can be detected on PA images using breast
specimens confirmed as benignity or malignancy.
Materials and Methods
Study Sample
The study was approved by the Institutional Review Board of
Severance Hospital, Yonsei University Health System (4-2011-
0823). All patients were informed about their inclusion in the
study. Written consent was obtained from all subjects prior to their
biopsy procedures.
Among patients who were scheduled to undergo sequential 8-
gauge vacuum-assisted core needle biopsy procedures with
stereotactic guidance or US guidance for breast microcalcifications
Figure 1. Diagram demonstrates experimental arrangement (A) to acquire photoacoustic signal images from 8-gauge core-
biopsied breast specimens (B). To obtain 3-dimensional photoacoustic data, the probe was mechanically moved along the frame scanning
direction (B).
doi:10.1371/journal.pone.0105878.g001
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suspected to be malignancy by mammography (Breast Imaging
Reporting and Data System [BI-RADS] category 4 or 5), 11
patients agreed to participate in our study from April 2012 to
March 2013 and they were prospectively included in the
microcalcification group (all female; age, 31–74 years). Eleven
cores from the 11 patients were obtained and specimen
mammography was performed to confirm the presence of
microcalcifications in core samples. The control group consisted
of 5 patients (all female; age, 24–41 years) undergoing sequential
8-gauge vacuum-assisted core needle excision procedures with US
guidance for biopsy-proven fibroadenoma during the same period.
These patients were also prospectively included in our control
group with their consent. Specimen mammography of the 10 cores
obtained from the 5 patients was performed to confirm that the
cores of the control group revealed no microcalcifications. In all,
21 cores of breast tissue were obtained from the 16 patients who
were included in our study. Mammography was performed using
the Selenia full field digital mammography system (Lorad/
Hologic, Danbury, Conn). To allow correlation between the two
modalities, specimen mammographic images were acquired in 2
view image planes: top-down and lateral view. The number and
size of calcifications on each specimen mammography were
evaluated. The size of each calcification in the cores of the
microcalcification group was assessed using the longest diameter of
each calcification focus shown on specimen mammography.
Imaging System and Experimental Procedures
The experimental arrangement of the photoacoustic (PA) and
US imaging data acquisition system was assembled similar to our
previous experiments (Figure 1) [19]. The specimens were set on a
scatter-free gel pad (Parker Lab, Inc., Farfield, NJ, USA), which
was immersed in a 0.9% saline-filled container. The temperature
of the container was stably maintained at 24uC. To acquire PA
signals from the specimens, radiofrequency (RF) data were
captured with a commercial US scanner equipped with a
SonixTouch research package (Ultrasonix Corp., Vancouver,
BC, Canada) and a 7-MHz linear array (L14-5/38) connected to a
SonixDAQ parallel system. The Q-switch trigger of a Nd:YAG
laser excitation system (Surelite III-10 and Surelite OPO Plus,
Continuum Inc., Santa Clara, CA, USA) was sent to a
SonixTouch research package at 10 Hz of pulse repetition rate.
Whenever the US scanner received the scanline-generation
trigger, scanline RF data were acquired. The pulse length of the
emitted laser was 7 ns and its wavelength was controlled by a
software program in a personal computer. The distance between
the array transducer and breast specimen was fixed at 30 mm that
was longer than the transducer’s elevational focal depth of 16 mm.
Note that laser delivery was conducted by a custom bifurcated
optic fiber bundle and their optical fluency was focused at 30 mm
depth from the array transducer (Fiberoptic Systems, Inc., Simi
Valley, CA, USA). The imaging reconstruction was conducted
with an optimal sound speed of 1500 m/s [20]. Before performing
experiments to acquire PA signals, specimens were steeped in
Table 1. Baseline characteristics of 21 cases of the control and microcalcification groups.
Case age Pathologic diagnosis Assum-ed calcific-ation on PAI* Confirmed calcification on specimen mammography
Existence Number Size*
1 25 Fibroadenoma No No - -
2 43 Ductal carcinoma in situ Yes Yes 10 500 (210–830)
3 25 Fibroadenoma No No - -
4 24 Fibroadenoma No No - -
5 39 Fibroadenoma No No - -
6 31 Fibrocystic change Yes Yes 45 310 (190–940)
7 41 Fibroadenoma No No - -
8 43 Fibrocystic change Yes Yes 17 130 (90–220)
9 49 Ductal carcinoma in situ Yes Yes 16 160 (70–260)
10 41 Fibroadenoma Yes No - -
11 42 Fibrocystic change Yes Yes 41 325 (160–390)
12 47 Ductal carcinoma in situ Yes Yes 27 220 (110–250)
13 24 Fibroadenoma No No - -
14 48 Ductal carcinoma in situ Yes Yes 14 280 (140–430)
15 24 Fibroadenoma Yes No - -
16 29 Fibroadenoma No No - -
17 41 Fibroadenoma No No - -
18 46 Columnar cell change Yes Yes 1 230
19 59 Sclerosing adenosis Yes Yes 22 220 (80–760)
20 39 Fibrocystic change No Yes 29 265 (120–390)
21 74 Ductal carcinoma in situ Yes Yes 17 290 (110–1000)
*Median value (range) of the diameter in calcifications (mm).
Abbreviations: PAI, photoacoustic Imaging.
doi:10.1371/journal.pone.0105878.t001
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saline solution for about 6 hours in order to exclude potentially-
remaining blood. This procedure was required when only
investigating PA signals generated from microcalcifications with-
out any interference from hemoglobin in blood.
The locations of the breast microcalcifications that appeared in
PA images were verified by comparing them with those in
specimen mammography. For this, 3-dimensional PA images were
acquired through mechanical scanning along the elevation
direction of an US array transducer at 0.3 mm increments. For
3-dimensional data, the XYZ-axis mechanical scanner and its
driver (SGSP26-100 and SHOT-204MS, Sigma Koki, Co., Ltd.,
Tokyo, Japan) were implemented with LabVIEW software
(National Instruments, Corp., Austin, TX, USA). With the
acquired 3-dimensional RF data from the experimental setup,
projected PA images in top-down and lateral directions were
reconstructed through programmed software of MATLAB (Math-
works, Inc., Natick, MA, USA).
A previous study had demonstrated that microcalcifications in
the breast tissue highly absorb laser pulses having a 700 nm
wavelength and that the laser energy absorbance consistently
decreased from 700 nm to the near infrared range [18]. Based on
this result, PA signals were generated by transmitting laser pulses
with two different wavelength sections as follows: 700 nm and
800 nm. The researchers performing all experimental procedures
were blinded to the findings of specimen mammography.
Figure 2. Representative case from ex vivo experiments with core specimens of breast tissue included in the microcalcification
group (case #2). Specimen mammography (A) and photoacoustic images obtained from both 700 nm (B) and 800 nm (C) wavelengths were
reconstructed with comparable configurations in both directions (top-down and lateral views). The locations of photoacoustic signals were well
matched with microcalcifications observed in specimen mammography. The photoacoustic image at 800 nm (C) showed decreasing photoacoustic
signal intensities in the region confirmed as microcalcifications through specimen mammography compared with the photoacoustic image at
700 nm (B). The mean value of PAI ratio{ from region of interest was 2.80. Abbreviations: PAI ratio, calculated ratio of the amplitude occurring at the
700 nm wavelength section to that occurring at the 800 nm wavelength section.
doi:10.1371/journal.pone.0105878.g002
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Data Analyses
After the experiments were done, 2 radiologists blindly reviewed
3-dimensional PAI data of each core in order to identify
microcalcifications within the core and to verify their locations.
The presence and location of microcalcifications in PA images of
each core were determined when the two radiologists reached an
agreement. They found foci that showed PA signals with maximal
amplitude on 700 nm and decreased or disappeared PA signals on
800 nm. Each core was then placed into one of two groups after
completion of the blind review: those with assumed microcalcifi-
cations detected on PA images or those with no microcalcifications
identified on PA images. The presence and location of microcal-
cifications appearing in PA images were demonstrated by
comparing them with those in specimen mammography. To
verify this visual assessment, we measured quantitative PA
responses from selected regions of interest (ROIs) which were
drawn manually in the core and calculated the ratio of the
amplitude occurring at the 700 nm wavelength section to the
amplitude occurring at the 800 nm wavelength section of each
focus. The ratio was called a PAI ratio in this paper.
Continuous data including size of calcifications are presented as
medians (with ranges). Comparisons between the control group
and microcalcification group were performed using the Mann-
Whitney U test for continuous variables. In the microcalcification
group, multiple regression analysis estimated the relationship
between the PAI ratio and other variables. Analysis was performed
using SPSS statistical software (SPSS Inc., Chicago, IL, ver 20.0),
and statistical significance was accepted as p-value ,0.05.
Results
Baseline Characteristics
The average age of the 16 patients in this study was 43.81 years
(24–74 years). The 11 patients included in the microcalcification
group were diagnosed as follows: ductal carcinoma in situ (DCIS)
(n = 5), fibrocystic change (n= 4), sclerosing adnenosis (n = 1), and
columnar cell change (n= 1).
Each focus of the cores assumed to be found with microcalci-
fications detected on PA images was matched against existing
microcalcifications confirmed by specimen mammography. Ta-
ble 1 summarizes our 21 cases and shows whether microcalcifi-
cations were identified or not on PA images and specimen
mammography. The number of calcifications-foci of each core in
the microcalcification group ranged from 1 to 45 (mean number,
21.73). The median size of calcifications within the cores is also
summarized in Tab. 1 and ranges from 130 to 500 mm.
Figure 3. Representative case from ex vivo experiments with core specimens of breast tissue included in the control group (case
#5). Specimen mammography (A) and photoacoustic images (B, C) were reconstructed with comparable configurations in both directions (top-
down and lateral views). The photoacoustic image at 800 nm (C) shows constant photoacoustic signal intensities from an unidentified target
compared with the photoacoustic image at 700 nm (B). The signal foci in the region of interest are assumed to be in the core. All these foci show
constant photoacoustic intensities. The mean value of PAI ratio{ from region of interest within this core was 1.21. The other bright signal foci around
the core may be photoacoustic signals from the interfaces between the surfaces of specimen and the gel pad, which show grossly constant
photoacoustic signal intensities. Abbreviations: PAI ratio, calculated ratio of the amplitude occurring at the 700 nm wavelength section to that
occurring at the 800 nm wavelength section.
doi:10.1371/journal.pone.0105878.g003
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Detection of Microcalcifications on Photoacoustic Images
Based on the change of PA signal amplitude between 700 nm
and 800 nm, 10 out of 11 specimens containing microcalcifica-
tions were chosen correctly by the two radiologists identifying the
right location of the microcalcifications and 8 out of 10 specimens
without calcifications were also identified correctly by the
radiologists (Table 2); the sensitivity, specificity, accuracy, positive
predictive and negative predictive values of our blinded review
were 90.91%, 80.0%, 85.71%, 83.33% and 88.89%, respectively.
With regard to the quantitative analysis of PA change, the cores in
the microcalcification group showed decreasing PA intensities in
the ROI which was proven to be the region containing
microcalcifications by specimen mammography (compare Fig-
ure 2B and Figure 2C). On the other hand, the cores belonging to
the control group showed constant PA intensities from unidentified
foci (compare Figure 3B and Figure 3C). Their changes are
summarized in Figure 4.
Comparison of Quantitative Photoacoustic Responses
To verify these changes in PA amplitude, we calculated the PAI
ratios of specimens included in the microcalcification group and
those of specimens included in the control group. All mean values
of PAI ratios from regions of interest within each core are
summarized in Table 3. The PAI ratio in the microcalcification
group was significantly higher than the PAI ratio of cores included
in the control group (median PAI ratio [range], 2.46 [1.03–3.92]
versus 1.10 [0.93–1.21], P=0.006), respectively (Figure 5).
To find factors that contribute to PAI ratios, we performed an
additional subgroup analysis in the microcalcification group. We
used a multivariable regression model with the dependent variable
of the PAI ratio and the independent predictors of other variables
(malignancy, number and size of calcifications-foci). On multiple
regression analysis, neither malignant diagnosis nor the number or
size of calcification-foci was proven to contribute to PAI ratios
(Table 4).
Figure 4. Change in mean values of the maximum photoacoustic signals at the 700 nm and 800 nm wavelength sections in the
control and microcalcification group.
doi:10.1371/journal.pone.0105878.g004
Table 2. Results of blind review to assume calcification on PAI.
Presence of Calcification Calcification on Specimen mammography Total
Yes No
Calcification on PAI1 Yes 10 2 12
No 1 8 9
Total 11 10 21
Abbreviations: PAI, photoacoustic Imaging.
doi:10.1371/journal.pone.0105878.t002
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Discussion
Visualization of microcalcifications by US examination has
been improved due to the development of high resolution US
[4,7,21–23]. However, the current US technology is still consid-
ered to be an unreliable method for the detection or evaluation of
microcalcifications compared to mammography in clinical use
[7,10,22–27]. A new commercial image processing technique to
show more microcalcifications than gray scale US was proposed
before, but it was merely an integrated software program that used
a filter technique in order to detect only isolated points using
higher brightness compared to the surrounding breast tissue [28].
Performers could become confused because of clustered micro-
calcifications or hyperechoic background including glandular and
Figure 5. The PAI ratio in the microcalcification group was significantly higher than that in the control group. Abbreviations: PAI ratio,
calculated ratio of the amplitude occurring at the 700 nm wavelength section to that occurring at the 800 nm wavelength section.
doi:10.1371/journal.pone.0105878.g005
Table 3. PAI ratios from regions of interest within each core.
Control group Microcalcification group P value
Case number PAI ratio Case number PAI ratio
1 1.18 2 2.80
3 1.14 6 2.63
4 1.06 8 3.19
5 1.21 9 1.68
7 1.08 11 3.0
10 1.12 12 1.79
13 1.11 14 2.46
15 0.93 18 1.03
16 1.10 19 3.92
17 1.03 20 1.06
21 1.60
Median value (range) 1.10 (0.93–1.21) Median value (range) 2.46 (1.03–3.92) 0.006
Abbreviations: PAI ratio, calculated ratio of the amplitude occurring at the 700 nm wavelength section to that occurring at the 800 nm wavelength section.
doi:10.1371/journal.pone.0105878.t003
Photoacoustic Imaging of Microcalcifications
PLOS ONE | www.plosone.org 7 August 2014 | Volume 9 | Issue 8 | e105878
fibrous tissue [28]. Thus, an imaging technique intrinsically based
on microcalcifications is indeed required.
We hypothesized that microcalcifications would have distin-
guishable absorbance-characteristics from surrounding breast
tissue through PA technology and we proved this hypothesis.
But, unfortunately, we used biopsy-specimens which were soaked
in saline solution causing elimination of blood. Hemoglobin inside
breast tissue also has been imaged by PA technology; there may be
concern over intervening of hemoglobin when acquiring PA
images of microcalcifiations since it is known that oxy-hemoglobin
shows increase in absorbance as the wavelength increases from
700 nm to 800 nm and deoxy-hemoglobin demonstrates peak
amplitude around 756 nm wavelength. Despite this limitation
which is inevitable in the ex vivo study, clinical use of PAI has a
promising future since breast microcalcifications have distinguish-
ing absorption spectra in response to different laser emissions
[18,19,29–32]. Further to spectral distinction, we may overcome
the limitation applying the principle of Doppler effect or time-of-
flight effect in the future in vivo study. Breast microcalcifications is
a static image, while hemoglobin makes a kinetic image causing
inflow/outflow process. As a result, we expect the problem
regarding the flow of blood to be resolved if kinetic images of
vascular flow is technically eliminated from the surrounding static
images. Therefore, the characteristic absorption spectrum of
microcalcifications in response to a specific wavelength of laser
pulse and their stationary temper allows PAI to depict distin-
guishable microcalcifications compared to surrounding in vivo
breast.
Previously, 3-dimantional PA images of a couple of benign
microcalcification cases were shown to detect breast microcalci-
fications which were well correlated with detection results of
specimen mammography. Further to previous case reports, we
proposes the feasibility of PAI with larger sample size including
malignant-confirmed microcalcification cases and provides satis-
tical analysis about PA signal intensities at the same time.
Curiously enough, the cores of both the microcalcifications and
control group presented unidentified PA signal foci because all
molecules, including not only microcalcifications but also sur-
rounding tissues in the core, generated PA signals in response to
the emitted laser. In addition, unspecified PA signal foci may also
originate from the interfaces between the surfaces of the specimen
and the saline containing the specimen or the gel pad supporting
the specimen. But, these unspecified foci disclosed constant PA
signal intensities regardless of wavelength change whereas PA
intensities obtained from ROIs of microcalcifications showed
characteristic change of PA signal amplitude (median PAI ratio,
1.11 in the control group versus 2.46 in the microcalcification
group, P=0.006). As a result, a practical measure to ensure that
clear PA images are obtained from just microcalcifications is
urgently needed when PAI is applied to human breasts in vivo.
Subtraction images can be reconstructed with the difference of PA
intensities in microcalcifications. This subtraction which reflects
PAI ratio and allows enhancing contrast resolution would be one
of the solutions for practical use of PAI.
In this study, with the use of PAI, a sensitivity of 90.91% and a
specificity of 80.0% for detection of microcalcifications within the
specimens were achieved although false positive (n = 2) and false
negative (n = 1) results were found. This may be because the
blinded review to find microcalcifications on PA images did
depend on the gross judgment of the two radiologists. The
subtraction images which might reflect PAI ratio would make it
easier for performers to detect microcalcifications and resolve false
positive or false negative results. For clinical application of PAI,
technically improved transducer with a program exhibiting
subtraction images concurrently should be developed to emphasize
and maximize contrast between microcalcifications and surround-
ing tissues.
There have been several attempts to identify underlying
biochemical differences that distinguish benign from malignant
microcalcifications, but a definite difference in chemical compo-
sition has not been clarified yet [33–37]. Two major types of
microcalcifications found in breast tissue (calcium oxalate and
hydroxyapatite) have been investigated by Raman spectroscopy
[11,38–40]. Although only benign calcification cases were
included, the possibility of different PAI ratios between malignant
and benign microcalcifications was mentioned through phantom
experiments of calcium oxalate and hydroxyapatite [19]. Instead
of analyzing the chemical composition inside the cores, we tried to
find factors contributing to different PA signal amplitudes of
calcifications, especially including malignant diagnosis as one of
the independent predictors. No significant factors were found
among variables such as malignant diagnosis as well as the number
and size of calcification-foci in the subgroup analysis (n = 11). In
order to clarify the difference of PAI ratio according to the
intrinsic character of calcifications, we will need to perform PAI
with increased sample size and should measure the quantitative
PA response of calcium oxalate and hydroxyapatite in the future;
their absorbance features might differentiate each other, which is
consistent with previous reports about calcium oxalate and
hydroxyapitite in breast lesions [3,33,38,41].
Our study still has a number of limitations. First of all, our
sample size is relatively small as it is one of the preliminary studies
about PAI of breast microcalcifications. Therefore, further studies
with larger sample sizes will be necessary. Second, since this is a
pilot study with biopsy specimens, practical application might still
be limited. Further prospective studies should be performed by
developing a sophisticated PA transducer and controlling unex-
pected properties of PA signals that might occur in its in-vivo use.
Table 4. Multiple regression analysis in the microcalcification group (n = 11) to find factors that contribute to PAI ratios.
Beta (standard error) P value
Variables
Malignant diagnosis* 20.346 (0.707) 0.639
Number of calcification-foci in the core{ 0.001 (0.004) 0.717
Size of calcification-foci in the core{ 0.013 (0.028) 0.653
*Malignant result according to the pathology report.
{Median value of calcification-foci in the core.
Abbreviations: PAI ratio, calculated ratio of the amplitude occurring at the 700 nm wavelength section to that occurring at the 800 nm wavelength section.
doi:10.1371/journal.pone.0105878.t004
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In conclusion, breast microcalcifications generated distinguish-
able photoacoustic signals unlike breast tissues without calcifica-
tions. So, PAI, a non-ionizing and non-invasive hybrid imaging
technique, can propose an alternative in overcoming the
limitations of the conventional US imaging.
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